1991
DOI: 10.1007/bf00003919
|View full text |Cite
|
Sign up to set email alerts
|

Production of the antibiotic cyanobacterin LU-1 by Nostoc linckia CALU 892 (cyanobacterium)

Abstract: Cyanobacterin LU-1, produced by Nostoc linckia CALU 892, inhibits the growth of many cyanobacteria and eukaryotic algae. The minimum effective dose of a crude preparation to Synechococcus sp. R-2 is ca 1 g ml-1. The antibiotic hinders cell division and light-dependent oxygen evolution in Synechococcus sp. R-2 (PCC 7942) cells. It is not active against heterotrophic bacteria and fungi, and is non-toxic to mice.Purified cyanobacterin LU-1 contains a nitrous heterocycle with sugar and phenolic substituents. Cyano… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
31
0
2

Year Published

1997
1997
2023
2023

Publication Types

Select...
4
3
3

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(34 citation statements)
references
References 4 publications
1
31
0
2
Order By: Relevance
“…Nutrients interfered with the production of these allelopathically active compounds (Ray and Bagchi, 2001). Nostoc linckia produced and released another allelochemical named cyanobacterin LU-1 that inhibited the growth of many cyanobacteria and eukaryotic algae but not heterotrophic bacteria and fungi (Gromov et al, 1991). Nostoc strain 31 produces cyclic heptapeptides, nostocyclamide and nostocyclamide M, which are allelopathically active against cyanobacteria and algae (Todorova and Jüttner, 1995;Jüttner et al, 2001).…”
Section: Cyanobacteriamentioning
confidence: 99%
“…Nutrients interfered with the production of these allelopathically active compounds (Ray and Bagchi, 2001). Nostoc linckia produced and released another allelochemical named cyanobacterin LU-1 that inhibited the growth of many cyanobacteria and eukaryotic algae but not heterotrophic bacteria and fungi (Gromov et al, 1991). Nostoc strain 31 produces cyclic heptapeptides, nostocyclamide and nostocyclamide M, which are allelopathically active against cyanobacteria and algae (Todorova and Jüttner, 1995;Jüttner et al, 2001).…”
Section: Cyanobacteriamentioning
confidence: 99%
“…A ce titre, les possibilités de valorisation de cette richesse naturelle apparaissent donc très importantes. De nombreux produits intéressant les industries chimiques, agroalimentaires, pharmaceutiques, cosmétiques et autres peuvent être extraits de bio-masses d'algues (Debro & Ward 1979, Leavitt 1983, Fattom & Shilo 1984, Moulton et al 1987, Borowitzka 1988a, Cannell et al 1988, Schwartz et al 1988, Gromov et al 1991. Par ailleurs, leur composition biochimique, particulièrement intéressante (teneur élevée en protéines, bonne composition en acides gras et acides aminés), en fait une source alimentaire de bonne qualité tant pour les animaux que pour les humains (Becker 1988).…”
Section: Introductionunclassified
“…7. possesses algicidal compounds like Crytophycin-A and nestodione-A, hexapeptides, Cyanobacterin LU-1 and LU-2 30 . Compounds isolated from cyanobacteria act on the photosynthetic electron transport chain (ETC), proton coupling, pigment synthesis and photo-oxidative effects and synthesis of amino acids 31 .…”
Section: Gc-ms Analysis Of Nostoc Sp Extractmentioning
confidence: 99%